MORPHOMER

Welcome to the Brand page for “MORPHOMER”, which is offered here for Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, pet-imaging compounds, all for medical purposes; chemical preparations for medical purposes, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; pet-imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in pet imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes;chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, pet-imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use;scientific and technological services, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, pet-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, vaccine and antibody engineering;.

Its status is currently believed to be active. Its class is unavailable. “MORPHOMER” is believed to be currently owned by “AC Immune SA”.